Shockwave Medical, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization
Loss from equity method investment
Stock-based compensation
Non-cash lease expense
Amortization of premium and discount on available-for-sale securities
Loss on write down of fixed assets
Change in fair value of warrant liability
Loss on extinguishment of debt
Deferred income taxes
Amortization of debt issuance costs
Foreign currency remeasurement
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued and other current liabilities
Lease liabilities
Increase (Decrease) in Income Taxes Payable

Net cash provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of available-for-sale securities
Proceeds from maturities of available-for-sale securities
Purchase of property and equipment
Payments to Acquire Businesses, Net of Cash Acquired
Net cash (used in) provided by investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock in public offering, net of issuance costs paid
Proceeds from issuance of common stock in private placement
Issuance of common stock in public offering, net of issuance costs
Payments of taxes withheld on net settled vesting of restricted stock units
Payment of deferred offering costs
Proceeds from debt financing
Proceeds from Convertible Debt
Purchases of capped calls related to convertible debt
Payment For Assumed Warrant Liabilities
Proceeds from stock option exercises
Proceeds from warrant exercises
Principal payment of term loan
Proceeds from issuance of common stock under employee stock purchase plan
Repayments of long-term debt
Net cash provided by (used in) financing activities

Effect of exchange rate changes on cash and cash equivalents
Net increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash equivalents at end of period
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid
Income tax paid
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued on conversion of convertible preferred stock
Offering cost included in account payable and accrued liabilities
Common stock warrants issued on conversion of preferred stock warrants and the reclassification of the warrant liability
Right-of-use asset obtained in exchange for lease liability
Property and equipment purchases included in accounts payable and accrued liabilities
Equity method investment obtained in exchange for related party contract liability
Transfer of fixed assets to inventory

Comments